A blog about chemistry, drug development, science, and technology
As if Merck needed more controversy. It seems that they now have a potential tax problem with the US and Canada for $5.58 billion dollars.
While I’m not a tax expert at all, I find this interesting since GlaxoSmithKline also has had some tax problems. I’m not sure why these are coming to the fore now but they seem to have to do with how revenues are recognized.
Merck’s CEO seems totally unconcerned by this and said he doesn’t lose any sleep over it. While, I’m not saying he should lose sleep, I think it should be at least somewhat seriously. Underestimating anyone is a common problem in warfare and in business.
Technorati Tags: Merck, tax problem
Bookmark it with:
|
del.icio.us
|
Digg it
|
Furl
|
Simpy
|
Spurl
|
My Yahoo!
|
[powered by WordPress.]
QDIS: blogging about chemistry, drug development, science and technology.

By Category
Chemistry, science, and technology for the future.

35 queries. 0.972 seconds
January 27th, 2007 at 1:46 pm
Thanks man, i agree